$2.81
-0.69-19.71%
Last update: Nov 5, 1:52 PM

The average analyst price target for Intensity Therapeutics is $39.25, 1296.8% above the current price. Of 4 analysts, 3 rate it Buy and 1 Hold. Targets range from $7 to $75. The latest change came on Aug 18, 2026, when HC Wainwright & Co. raised its price target on Intensity Therapeutics from $5 to $7 and kept a Buy rating.
Price Target Range — 9 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months